BIOMARIN PHARMACEUTICAL INC Payments to Acquire Interest in Joint Venture
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Payments to Acquire Interest in Joint Venture of $1.10 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-02.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInterestInJointVenture · last filed 2015-03-02
- BIOMARIN PHARMACEUTICAL INC payments to acquire interest in joint venture for the quarter ending 2014-12-31 was $0.00, a 100.00% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC payments to acquire interest in joint venture for the quarter ending 2014-09-30 was $600.00K.
- BIOMARIN PHARMACEUTICAL INC payments to acquire interest in joint venture for the quarter ending 2013-12-31 was $400.00K, a 17.53% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC payments to acquire interest in joint venture for the quarter ending 2013-09-30 was $0.00.
- BIOMARIN PHARMACEUTICAL INC payments to acquire interest in joint venture for fiscal 2014 was $1.10M, a 24.29% increase from fiscal 2013.
- BIOMARIN PHARMACEUTICAL INC payments to acquire interest in joint venture for fiscal 2013 was $885.00K, a 49.23% decline from fiscal 2012.
- BIOMARIN PHARMACEUTICAL INC payments to acquire interest in joint venture for fiscal 2012 was $1.74M, a 8.41% decline from fiscal 2011.
- BIOMARIN PHARMACEUTICAL INC payments to acquire interest in joint venture for fiscal 2011 was $1.90M, a 47.62% decline from fiscal 2010.
| Period end | Payments to Acquire Interest in Joint Venture 3 month | Payments to Acquire Interest in Joint Venture 6 month | Payments to Acquire Interest in Joint Venture 9 month | Payments to Acquire Interest in Joint Venture 12 month |
|---|---|---|---|---|
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $600.00K derived: sum of 2 quarters · filed 2015-03-02 | $1.10M 10-K · filed 2015-03-02 | |
| 2014-09-30 | $600.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-28 | $1.10M 10-Q · filed 2014-10-28 | ||
| 2014-06-30 | $500.00K 10-Q · filed 2014-07-31 | |||
| 2013-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $400.00K derived: sum of 2 quarters · filed 2015-03-02 | $885.00K derived: sum of 3 quarters · filed 2015-03-02 | $885.00K 10-K · filed 2015-03-02 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-28 | $485.00K derived: sum of 2 quarters · filed 2014-10-28 | $485.00K 10-Q · filed 2014-10-28 | $970.00K derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | $485.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $485.00K 10-Q · filed 2014-07-31 | $970.00K derived: sum of 3 quarters · filed 2015-03-02 | $970.00K derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $0.00 10-Q · filed 2013-04-29 | $485.00K derived: sum of 2 quarters · filed 2015-03-02 | $485.00K derived: sum of 3 quarters · filed 2015-03-02 | $485.00K derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | $485.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $485.00K derived: sum of 2 quarters · filed 2015-03-02 | $485.00K derived: sum of 3 quarters · filed 2015-03-02 | $1.74M 10-K · filed 2015-03-02 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | $0.00 derived: sum of 2 quarters · filed 2013-10-28 | $1.26M 10-Q · filed 2013-10-28 | $1.26M derived: sum of 4 quarters · filed 2014-02-26 |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-29 | $1.26M 10-Q · filed 2013-07-29 | $1.26M derived: sum of 3 quarters · filed 2014-02-26 | $1.91M derived: sum of 4 quarters · filed 2014-02-26 |
| 2012-03-31 | $1.26M 10-Q · filed 2013-04-29 | $1.26M derived: sum of 2 quarters · filed 2014-02-26 | $1.91M derived: sum of 3 quarters · filed 2014-02-26 | $2.57M derived: sum of 4 quarters · filed 2014-02-26 |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | $655.00K derived: sum of 2 quarters · filed 2014-02-26 | $1.31M derived: sum of 3 quarters · filed 2014-02-26 | $1.90M 10-K · filed 2014-02-26 |
| 2011-09-30 | $655.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-29 | $1.31M derived: sum of 2 quarters · filed 2012-10-29 | $1.90M 10-Q · filed 2012-10-29 | $2.62M derived: sum of 4 quarters · filed 2013-02-26 |
| 2011-06-30 | $655.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | $1.25M 10-Q · filed 2012-08-02 | $1.97M derived: sum of 3 quarters · filed 2013-02-26 | $3.42M derived: sum of 4 quarters · filed 2013-02-26 |
| 2011-03-31 | $593.00K 10-Q · filed 2012-04-30 | $1.31M derived: sum of 2 quarters · filed 2013-02-26 | $2.76M derived: sum of 3 quarters · filed 2013-02-26 | $2.76M derived: sum of 4 quarters · filed 2013-02-26 |
| 2010-12-31 | $718.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $2.17M derived: sum of 2 quarters · filed 2013-02-26 | $2.17M derived: sum of 3 quarters · filed 2013-02-26 | $3.63M 10-K · filed 2013-02-26 |
| 2010-09-30 | $1.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | $1.45M derived: sum of 2 quarters · filed 2011-10-31 | $2.92M 10-Q · filed 2011-10-31 | $3.65M derived: sum of 4 quarters · filed 2012-02-22 |
| 2010-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-01 | $1.47M 10-Q · filed 2011-08-01 | $2.21M derived: sum of 3 quarters · filed 2012-02-22 | $2.94M derived: sum of 4 quarters · filed 2012-02-22 |
| 2010-03-31 | $1.47M 10-Q · filed 2011-04-29 | $2.21M derived: sum of 2 quarters · filed 2012-02-22 | $2.94M derived: sum of 3 quarters · filed 2012-02-22 | |
| 2009-12-31 | $740.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $1.48M derived: sum of 2 quarters · filed 2012-02-22 | $2.12M 10-K · filed 2012-02-22 | |
| 2009-09-30 | $740.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-29 | $1.38M 10-Q · filed 2010-10-29 | ||
| 2009-06-30 | $640.00K 10-Q · filed 2010-08-04 | |||
| 2008-12-31 | $1.75M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |